Document is current
Any future updates will be listed below
-
Authors
Lind, Viktor http://orcid.org/0000-0002-6123-3591
Hammar, Niklas
Lundman, Pia
Friberg, Leif
Talbäck, Mats
Walldius, Göran
Norhammar, Anna
-
Funding
Funding for this research was provided by:
Hjärt-Lungfonden (20180524, 20170367)
Hjärtat foundation at Danderyds hospital
Gunnar & Ingmar Jungner Foundation of Laboratory Medicine
Karolinska Institute
- License Information
-
More Information
Article History
Received: 4 October 2021
Accepted: 15 November 2021
First Online: 24 November 2021
Declarations
:
: This study complies with the Declaration of Helsinki and was approved by the Regional Ethical Review Board in Stockholm (Reg.No. 2010/1047-31/1). No written consent was required.
: Not applicable.
: The authors declare that they have no conflicts of interest concerning this article. VL has nothing to disclose. NH has nothing to disclose. PL reports personal fees from Boehringer Ingelheim, personal fees from Sanofi, personal fees from Novo Nordisk, outside the submitted work. LF reports personal fees from Bayer, personal fees from Boehringer Ingelheim, personal fees from BMS, personal fees from Pfizer, personal fees from Sanofi, outside the submitted work. MT has nothing to disclose. GW has nothing to disclose. AN reports personal fees from Astra Zeneca, personal fees from MSD, personal fees from Boehringer Ingelheim, personal fees from Lilly, personal fees from Novo Nordisk, outside the submitted work.
